Patients were classified according to whether or not they had a PAC at any time during their ICU stay, and were followed up until death, hospital discharge, or for 60 days. Propensity score case matching was performed, and matched pairs were examined for baseline characteristics and outcome. Of 3,147 patients, 481 patients (15.3%) had a PAC. Patients with a PAC were older, had a higher incidence of heart failure, a lower incidence of cancer, and were more commonly surgical admissions. Fluid balance was comparable between the two groups. ICU and hospital mortality rates were higher in patients with a PAC (28.1% vs 16.8% and 32.5% vs 22.5%, respectively; p < 0.001). However, PAC use was not an independent risk factor for 60-day mortality in multivariate analysis, and in 453 propensity-matched pairs ICU and hospital mortality rates were comparable between groups (26.7% vs 26.3% and 31.4% vs 32.8%, p ‫؍‬ not significant). Survival to 60 days was similar between the two matched groups (log rank ‫؍‬ 0.02; p ‫؍‬ 0.894). 
Use of the Pulmonary Artery Catheter Is Not Associated With Worse Outcome in the ICU* hemodynamic monitoring. [2] [3] [4] [5] [6] [7] [8] Although the impact of PAC insertion on patient outcome has been questioned in several investigations, no clear conclusion has been reached. Several studies 9 -11 have suggested that the use of the PAC in critically ill patients may result in worse outcomes, although others [12] [13] [14] [15] have not confirmed these findings. A particularly famous, prospective cohort study by Connors et al, 9 which involved a mixed population of medical and surgical ICU patients, suggested increased mortality, length of stay, and costs associated with the use of PAC. This study 9 and the accompanying editorial 16 caused turmoil among intensivists and generated intense interest in the lay press. 17 The results of this study 9 have been widely debated, 18 and a call for either a moratorium or randomized control studies was even proposed by some authors. 16, 19 A French multicenter, randomized controlled study 20 noted that early PAC use in patients with shock or ARDS did not significantly affect mortality or morbidity, similar to the results of an earlier, smaller study 21 in the United Kingdom. Another controlled study 22 in high-risk surgical patients failed to show any benefit of PAC use. However, controlled studies could be limited by methodologic problems, including selection bias, noncompliance by physicians, and crossover from the control group to use of PAC. 23 Observational studies may, therefore, provide beneficial information; however, careful consideration and correction for all possible confounding variables is mandatory.
In this large cohort of critically ill patients included in the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study, we addressed the epidemiology of PAC use in European ICUs and examined the possible association between PAC use and outcome. We applied two methods to test for adjusting for confounding variables: multivariate regression analysis and propensity score case matching.
Materials and Methods

Study Design
This report is the result of a substudy from the SOAP database, a prospective, multicenter, observational study that was designed to evaluate the epidemiology of sepsis in European countries and was initiated by a working group of the European Society of Intensive Care Medicine. Institutional recruitment for participation was by open invitation from the study steering committee to European ICUs. Since this epidemiologic, observational study did not require any deviation from routine medical practice, institutional review board approval was either waived or expedited in participating institutions, and informed consent was not required. We included all adult patients (Ͼ 15 years old) admitted to the participating centers (a list of participating countries and centers is given in the Appendix) between May 1, 2002, and May 15, 2002 . Patients were followed up until death, hospital discharge, or for 60 days. Those who stayed in the ICU for Ͻ 24 h for routine postoperative observation were excluded.
Data Management
Data were collected prospectively using preprinted case report forms. Detailed instructions, explaining the aim of the study, instructions for data collection, and definitions for various important items were available for all participants at www.intensive.org before starting data collection and throughout the study period. The steering committee processed all queries during data collection.
Data were entered centrally by medical personnel using statistical software (SPSS version 11.0 for Windows; SPSS; Chicago, IL). A random sample of 5% of data were re-entered by a different encoder and revised by a third encoder; a consistency of Ͼ 99.5% per variable and 98.5% per patient was observed during the whole process of data entry. In case of inconsistency, data were verified and corrected. Daily frequency tables were revised for all variables, and the investigators were questioned when data values were either questionable or missing for required fields. Data collection on admission included demographic data and comorbid diseases. Clinical and laboratory data for simplified acute physiology score (SAPS) II 24 were reported as the worst value within 24 h after hospital admission. Microbiologic and clinical infections were reported daily as well as the antibiotics administrated. A daily evaluation of organ function that was based on a set of laboratory and clinical parameters according to the sequential organ failure assessment (SOFA) score 25 was performed, with the most abnormal value for each of the six organ systems (ie, respiratory, renal, cardiovascular, hepatic, coagulation, and neurologic) being collected on admission and every 24 h thereafter. For a single missing value, a replacement was calculated using the mean value of the results on either side of the absent result. When first or last values were missing, the nearest value was carried backward or forward respectively. When more than one consecutive result was missing, it was considered to be a missing value in the analysis.
Definitions
Infection was defined as the presence of a pathogenic microorganism or clinical infection necessitating antibiotic administration. Sepsis, severe sepsis, and septic shock were defined according to the American College of Chest Physicians/Society of Critical Care Medicine consensus conference definitions. 26 Circulatory shock was defined as a cardiovascular SOFA score Ͼ 2; ie, the use of dopamine at a dose Ͼ 5 g/kg/min and/or epinephrine or norepinephrine at any dose. To allow for the difference between colloid and crystalloid solutions, 27 we calculated the adjusted fluid balance by multiplying the amount of colloid given by three.
Statistical Methods
Data were analyzed using statistical software (SPSS version 11.0 for Windows; SPSS). Descriptive statistics were computed for all study variables. The Kolmogorov-Smirnov test was used, and stratified distribution plots were examined to verify the normality of distribution of continuous variables. Nonparametric tests of comparison were used for variables evaluated as not normally distributed. Difference testing between groups was performed using the two-tailed t test, Mann-Whitney U test, 2 test, and Fisher Exact Test as appropriate. To determine the relative hazard of death (RH) due to PAC use, a multivariate Cox proportional hazard model 28 was constructed with time to death right censored at 60 days as the dependent factor in the overall population. Variables considered for the Cox regression analysis included the following: age, gender, comorbid diseases and SAPS II score on hospital admission, the extent of organ failure as assessed by the SOFA, daily fluid balance, and the use of various vasopressors and colloids. Variables were introduced in the multivariate model if significantly associated with a higher risk of 60-day mortality on a univariate basis at a p value Ͻ 0.2. Coliniarity between variables was excluded prior to modeling. The time-dependent covariate method 28 was used to check the proportional hazard assumption of the model; an extended Cox model was constructed, adding interaction terms that involve time, ie, time-dependent variables, computed as the byproduct of time and individual covariates in the model (time ϫ covariate). Individual time-dependent covariates were introduced one by one and in combinations in the extended model, none of which was found to be significant (Wald 2 statistics). A forward stepwise approach was used, and the use of PAC was entered as the last step in the model after adjustment for other factors. Kaplan-Meier survival curves were plotted and compared using the signed log-rank test in the overall population and in the propensity score matched pairs. Propensity scores 29 were obtained through logistic regression of patient characteristics on PAC status (ie, actual use of PAC). A greedy matching technique 30 was used to match unique patients with PAC with unique patients without PAC based on propensity scores. The bestmatched propensity score was identical to five digits. Once a match was made, the control patient was removed from the pool. This process was then repeated using four-digit matching, then three-digit matching, etc. If a PAC patient matched with more than one control, a match was randomly selected. The process proceeded sequentially to a single-digit match on propensity score. If a match was not obtained at this point, the patient with PAC was excluded. All statistics were two tailed, and p Ͻ 0.05 was considered to be significant.
Results
Study Population
Of 3,147 patients included in the SOAP study, 481 patients (15.3%) had a PAC inserted, including 367 patients (11.7%) who had it introduced on the day of hospital admission, and 114 patients (3.6%) later. The median duration of PAC use was 3 days (interquartile range [IQR], 2 to 6 days), accounting for 1,917 of the total reported ICU days (8.7%) . The characteristics of the study group on hospital admission are presented in Table 1 . Patients with a PAC were older, had a higher incidence of heart failure, a lower incidence of cancer, and were more commonly surgical admissions than patients without a PAC. The SAPS II and SOFA scores and the incidence of sepsis syndromes were higher in the PAC group. Figure 1 represents the percentage of PAC use in the contributing countries.
Procedures and Fluid Administration
Mechanical ventilation and renal replacement therapy were performed more commonly in the PAC group than in other patients. Fluid balance was comparable between the two groups (Table 2) throughout the ICU stay. However, more hydroxyethyl starch, gelatin, albumin, and RBC transfusion were administered in the PAC group than in the other patients. Adjusted (colloid volume multiplied by three to adjust for intravascular effects) daily and total fluid balances were higher in patients with a PAC (Table 3) .
Morbidity and Mortality
The overall ICU and hospital mortality rates were 18.5% and 23.7%, respectively. Both ICU and hospital mortality rates were higher in patients with a PAC than in patients without PAC (28.1% vs 16.8% and 32.5% vs 22.5%, respectively; both p Ͻ 0.001) [ Table 4 ]. The mean and maximum SOFA scores, and the ICU length of stay were higher in the PAC group than in the other patients. ICU-acquired infection rates were higher in patients with a PAC than others (11.4% vs 8.4%, p ϭ 0.031). Respiratory tract infections were the most common ICU-acquired infection in the PAC group (78.2%). Only eight patients (1.8%) in the PAC group had a catheter-related infection. Patients with a PAC had lower survival until day 60 (Fig 2, top, A) than those without a PAC (log rank ϭ 14.04; p Ͻ 0.001).
Risk of Death From PAC Insertion
In univariate analysis, PAC use was associated with a higher risk of 60-day mortality in the overall population (RH, 1.42; 95% confidence interval, 1.19 to 1.7). In a multivariate Cox regression forward stepwise analysis, PAC use was not independently associated with a higher risk of 60-day mortality (Table 5) . Factors associated independently with a higher risk of 60-day mortality included higher SAPS II score, liver cirrhosis, medical admission, older age, HIV infection, and hematologic cancer.
Propensity Score Matching
A total of 453 pairs were matched according to their propensity score. Table 6 shows the characteristics of propensity-matched patients on hospital admission on the basis of age, gender, comorbidities, type of admission, SAPS II and SOFA scores, procedures, and sepsis syndromes. ICU and hospital In propensity-matched patients, actual and adjusted fluid balances were similar; however, dobutamine, albumin, and kestrel were administered more often in patients with a PAC (Table 7) . Survival to 60 days was similar in the two propensity-matched groups (log rank ϭ 0.02; p ϭ 0.894) [Fig 2, bottom, B] .
Discussion
In this observational study, as we might have expected, patients who received a PAC had higher ICU and hospital mortality rates than the other patients. However, after adjusting for the confounding factors using a Cox regression model or propensity score case matching, similar mortality rates were present in patients with and without a PAC.
There can be large international variations in the use of the PAC. Even in Europe, PAC use can vary markedly; in our study the overall incidence was 15.3% at any time during the ICU stay, mostly (11.7%) on the admission day. This incidence is comparable with another large European study performed 10 years ago, the European Prevalence of Infection in Intensive Care study, 31 involving Ͼ 10,000 patients, of which 12.8% had a PAC on the study day, suggesting that PAC use has remained relatively stable over time. However, these figures contrast with the high incidence in the north American study by Connors et al, 9 in which 38% of patients had a PAC within the first 24 h of hospital admission, raising the question of overzealous insertion and subsequent selection bias involving unnecessary insertion in patients who may suffer the complications of PAC rather than being able to benefit from it. Also, Connors et al 9 excluded 5% of patients who had a PAC inserted after 24 h of hospital admission with no rational explanation for this exclusion. These patients most probably represent a subgroup that might, in fact, have benefited from the PAC, as the authors alluded to in their discussion. We elected to include patients with a PAC inserted at any time during the ICU stay to avoid any selection bias.
In our study, the reason for the increased mortality and decreased survival in patients managed with a PAC is quite evident. As expected, patients with a PAC were older, had a higher incidence of heart failure, higher SAPS II and SOFA scores, and a greater incidence of sepsis syndromes. We used two methods to adjust for possible confounders: a multivariate logistic regression analysis using the Cox model, and propensity score case matching. In a multivariate analysis, the use of the PAC was not associated with an independent higher risk of death in our patients (n ϭ 4,147) after adjusting for age, sex, comorbidities on admission, type of admission, SAPS II score, the degree of organ failure assessed by the SOFA score, and the presence of sepsis syndromes on hospital admission. Factors independently associated with a higher risk of death at 60-day mortality included higher SAPS II score, liver cirrhosis, medical admission, older age, HIV infection, hematologic cancer, but not the use of a PAC. Propensity score technology, introduced by Rosenbaum and Rubin, 29 controls for naturally occurring systematic differences in the background characteristics between the treatment group (PAC group) and the control group (patients without PAC), by reducing the entire collection of these characteristics to a single composite that approximately summarizes the collection. This reduction from many characteristics to one composite characteristic allows the straightforward assessment of whether the treatment and control groups overlap enough with respect to background characteristics to allow a sensible estimation of treatment vs control effects from the data set. 32 The propensity score is found by predicting treatment group membership (the use of PAC) from the confounding covariates, for example, by a logistic regression analysis. Each person in the database then has an estimated propensity score, which is the estimated probability (as determined by that person's covariate values). Applications include matched sampling, subclassification, and covariate adjustment according to the propensity score. 29, 33 We used a multivariate logistic regression analysis with PAC use as the dependent factor. We adjusted for age, sex, comorbidities on admission, SAPS II score, the degree of organ failure assessed by the SOFA score, procedures on hospital admission, and presence of sepsis syndromes on hospital admission. The 453 propensity-matched pairs had comparable baseline characteristics. ICU and hospital mortality rates were comparable between the PAC group and their matched pairs, and survival to 60 days was similar between the two groups. The same technique of propensity score matching was used by Connors et al 9 ; however, of the 2,184 patients with a PAC in that study, only 1,008 patients (46.2%) were matched. The possible reason for this may be a failure of the 53.8% of patients with a PAC to match with patients from the control group due to defective overlap between the two groups, or the presence of missing values of the covariates included in the propensity score calculation. This defective matching could have introduced a major selection bias comparing the propensity-matched groups and raises questions about how representative these data are. In our study, as many as 94.2% of the patients with a PAC were matched to control patients, likely due to sufficient overlap between the two groups and the small number of missing values (Ͻ 1%). Also, we excluded uncomplicated patients admitted for postoperative monitoring Ͻ 24 h. Accordingly, selection bias is markedly minimized in our study compared with that by Connors et al. 9 In another study by Yu et al, 14 the authors also used propensity case matching and noted no negative effects of PAC insertion on outcome. However, this study used data that are now Ͼ 10 years old.
Several randomized controlled trials 20 -22 have found no differences in outcome between patients with and those without PACs. In high-risk surgical patients, Sandham et al 22 showed no significant difference in mortality between patients managed with a PAC and those without a PAC (7.7% vs 7.8%, p ϭ not significant). Similarly, in patients with shock or ARDS, Richard et al 20 noted that there were no significant differences in mortality with or without the PAC at day 14 or day 90. These authors also noted no differences in organ failure-free days, renal support, vasoactive agents, hospital or ICU stay, or mechanical ventilation use, although an earlier metaanalysis 34 of randomized controlled trials showed a significant reduction in morbidity, in terms of organ dysfunction, using PAC-guided strategies. Most recently, the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial, which included 433 patients with class IV advanced heart failure from 26 sites in the United States and Canada who were randomized to assessment with or without a PAC, found no differences in mortality rates or days hospitalized in patients with or without a PAC. 35 The study by Sandham and colleagues 22 reported a higher rate of pulmonary embolism in the catheter group than in the standard care group, although the cause effect relationship is questionable. In the French study, 20 there were few major complications, PAC-related infections occurred in 10 patients (2.8%), and there were no cases of pulmonary embolism. In the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness study, 35 approximately 4% of patients undergoing pulmonary artery catheterization had complications, including cardiac arrest and infection, but there were no PAC-related deaths. PAC-associated complications were difficult to assess in our study. However, complications of catheterization have not been emphasized in the literature. 18, 20 Our study is limited by the observational design. However, both the multivariate regression analysis and the propensity score matching yielded similar results. Other confounders not reported in our study could have contributed to either more beneficial or more deleterious effects due to PAC insertion. The heterogeneity of patients in our study is another important limitation, but it is difficult to identify a homogenous population in the ICU milieu due to marked overlap of disease processes.
It should be emphasized that we are evaluating a monitoring tool and not a new therapy. Proper collection and interpretation of data provided by the PAC with subsequent implementation of the results in clinical practice is mandatory to ensure a clear beneficial effect. Prognosis cannot be improved by catheter insertion per se. Accordingly, the call for a moratorium for the PAC use in the ICU is unjustified, and randomized controlled studies in specific subgroups of critically ill patients are impractical due to marked overlap between the different disease processes in the ICU. Improved training and proper implementation of the data provided by the PAC should reduce the complications related to its use and increase the beneficial effects.
Conclusion
In this multicenter, observational European study, a PAC was inserted in 15.3% of patients. PAC use was not associated with a worse prognosis after adjustment for possible confounders.
